Product Images Mesalamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Mesalamine NDC 68382-435 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Mesalamine Delayed-release Tablets, USP - d1574001 4164 4b13 b01a 568406c18f46 01

Mesalamine Delayed-release Tablets, USP - d1574001 4164 4b13 b01a 568406c18f46 01

This is not a valid molecular formula since it contains semicolons instead of subscripts. Therefore, it is not possible to generate a useful description.*

Mesalamine Delayed-release Tablets USP, 800 mg - d1574001 4164 4b13 b01a 568406c18f46 02

Mesalamine Delayed-release Tablets USP, 800 mg - d1574001 4164 4b13 b01a 568406c18f46 02

This text represents the label of a medication called Mesalamine which includes its NDC code (68382-435-28), its formulation (delayed-release tablets), its dosage strength (500mg), the number of tablets contained in the bottle (180), and the manufacturer (ZyDus Pharmaceuticals). The label also provides some instructions for use (i.e. take as directed), precautions (i.e. keep out of reach of children), and warnings (i.e. do not use if allergic to mesalamine).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.